GlassScriptPhysician profile
Caroline Rochon
NPI 1851521777
$7,535.10
in general payments reported to CMS, 2019-2025
14 companies · $6,402 in 2025
The $6,402 reported for 2025 was more than what 87% of Transplant Surgery providers received nationally (typical 2025 total: $423).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24.91 · 2020: $179 · 2021: $71.86 · 2022: $167 · 2023: $356 · 2024: $335 · 2025: $6,402.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,087 · Education: $2,500 · Food and Beverage: $1,506.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,086.76 |
| Education | $2,500.00 |
| Food and Beverage | $1,505.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,293.94 | 2020-2025 | |
| Sanofi-Aventis U.S. LLC | $522.77 | 2022-2024 | |
| Ethicon US, LLC | $200.96 | 2019-2024 | Proximate, Echelon Flex, Harmonic |
| Veloxis Pharmaceuticals, INC. | $196.68 | 2020-2025 | Envarsus |
| Takeda Pharmaceuticals U.S.A., INC. | $81.23 | 2022-2025 | Livtencity |
| Merck Sharp & Dohme LLC | $48.32 | 2024 | Prevymis |
| Vifor Pharma, INC. | $43.55 | 2024-2025 | Veltassa |
| Depuy Synthes Sales INC. | $33.39 | 2021 | |
| Lemaitre Vascular, INC. | $26.27 | 2025 | Artegraft Vascular Graft |
| Ipsen Biopharmaceuticals, INC | $21.38 | 2024 | Iqirvo |
| Madrigal Pharmaceuticals | $18.64 | 2025 | Rezdiffra |
| Eisai INC. | $18.45 | 2020 | |
| Mallinckrodt Hospital Products INC. | $15.45 | 2025 | Acthar |
| Genzyme Corporation | $14.07 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caroline Rochon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.